Staels, Bart

Alternative macrophages in atherosclerosis: not always protective!

Pourcet, B., & Staels, B. (2018) · Journal of Clinical Investigation

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 62

Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH)

Vandel, J., Dubois‐Chevalier, J., Gheeraert, C., Derudas, B., Raverdy, V., Thuillier, D., Gaal, L., Francque, S., Pattou, F., Staels, B., et al. (2021) · Hepatology

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 61

The transcriptional regulating protein of 132 kDa (TReP-132) enhances P450scc gene transcription through interaction with steroidogenic factor-1 in human adrenal cells

Gizard, F., Lavallée, B., DeWitte, F., Teissier, E., Staels, B., & Hum, D. W. (2002) · Journal of Biological Chemistry

Adrenal Hormones and DisordersEstrogen and related hormone effects

Cited by 58

Peroxisome proliferator-activated receptors—from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease

Bouhlel, M. A., Staels, B., & Chinetti‐Gbaguidi, G. (2008) · Journal of Internal Medicine

Peroxisome Proliferator-Activated ReceptorsCholesterol and Lipid Metabolism

Cited by 51

M1 and M2 macrophage proteolytic and angiogenic profile analysis in atherosclerotic patients reveals a distinctive profile in type 2 diabetes

Roma-Lavisse, C., Tagzirt, M., Zawadzki, C., Lorenzi, R., Vincentelli, A., Haulon, S., Juthier, F., Rauch, A., Corseaux, D., Staels, B., et al. (2015) · Diabetes and Vascular Disease Research

Atherosclerosis and Cardiovascular DiseasesImmune cells in cancer

Cited by 50

Endoplasmic reticulum stress actively suppresses hepatic molecular identity in damaged liver

Dubois, V., Gheeraert, C., Vankrunkelsven, W., Dubois‐Chevalier, J., Dehondt, H., Bobowski‐Gerard, M., Vinod, M., Zummo, F. P., Güiza, F., Ploton, M., et al. (2020) · Molecular Systems Biology

Liver physiology and pathologyEndoplasmic Reticulum Stress and Disease

Cited by 46

miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophages

Vinod, M., Chennamsetty, I., Colin, S., Belloy, L., De Paoli, F., Schaider, H., Graier, W. F., Frank, S., Kratky, D., Staels, B., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 44

Incretin combination therapy for the treatment of non-alcoholic steatohepatitis

Kannt, A., Madsen, A. N., Kammermeier, C., Elvert, R., Klöckener, T., Bossart, M., Haack, T., Evers, A., Lorenz, K., Hennerici, W., et al. (2020) · Diabetes, Obesity and Metabolism

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 37

Regulation of PPARα by APP in Alzheimer disease affects the pharmacological modulation of synaptic activity

Sáez-Orellana, F., Leroy, T., Ribeiro, F., Kreis, A., Leroy, K., Lalloyer, F., Baugé, E., Staels, B., Duyckaerts, C., Brion, J.-P., et al. (2021) · JCI Insight

Alzheimer's disease research and treatmentsPeroxisome Proliferator-Activated Receptors

Cited by 29

The logic of transcriptional regulator recruitment architecture at cis-regulatory modules controlling liver functions

Dubois-Chevalier, J., Dubois, V., Dehondt, H., Mazrooei, P., Mazuy, C., Sérandour, A. A., Gheeraert, C., Guillaume, P., Baugé, E., Derudas, B., et al. (2017) · Genome Research

Genomics and Chromatin DynamicsChromatin Remodeling and Cancer

Cited by 29

Modulation of inflammatory M1-macrophages phenotype by valvular interstitial cells

Tagzirt, M., Rosa, M., Corseaux, D., Vincent, F., Vincentelli, A., Daoudi, M., Jashari, R., Staels, B., Van Belle, E., Susen, S., et al. (2023) · The Journal of Thoracic and Cardiovascular Surgery

Cardiac Valve Diseases and TreatmentsAtherosclerosis and Cardiovascular Diseases

Cited by 6

An extended transcription factor regulatory network controls hepatocyte identity

Dubois‐Chevalier, J., Gheeraert, C., Berthier, A., Boulet, C., Dubois, V., Guille, L., Fourcot, M., Marot, G., Gauthier, K., Dubuquoy, L., et al. (2023) · EMBO Reports

Liver physiology and pathologyGene Regulatory Network Analysis

Cited by 6

Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation

Velagapudi, S., Miranda, M. X., Adla, P., Kraler, S., Mohammed, S. A., Baki, S., Robert, J., Rohrer, L., Lee, H., Jang, H.-D., et al. (2025) · Cardiovascular Research

Sirtuins and Resveratrol in MedicineCholesterol and Lipid Metabolism

Cited by 4

LIBX‐A401: A Novel Selective Inhibitor of Acyl‐CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode

Mazhari Dorooee, D., Ravez, S., Vertommen, D., Renault, N., Papadopoulos, N., Marteau, R., Charnelle, E., Porte, K., Gobert, A., Hennuyer, N., et al. (2025) · Angewandte Chemie

Ferroptosis and cancer prognosisCancer, Lipids, and Metabolism

Cited by 3